Rob Casalou, St. Joseph Mercy regional president and CEO, will serve as president and CEO of the merged system, effective Jan. 1, in today's bite-sized hospital and health industry news from Florida, Indiana, and Michigan.
Under new blood pressure guidelines from the American Heart Association and the American College of Cardiology, millions more Americans now qualify as having high blood pressure—but there are steps you can take to lower yours, Gina Kolata writes for the New York Times.
Federal funding for the Children's Health Insurance Program expired 47 days ago. This is not the first lapse in CHIP funding—but it is by far the longest, and lawmakers do not appear any closer to passing a renewal. The Daily Briefing explores the political and policy questions at play and how they differ from those during the 2007 funding gap.
The NSS-2 Bridge, manufactured by Innovative Health Solutions, is a small battery-powered cranial nerve stimulator that emits electrical pulses to provide patients with relief from opioid withdrawal symptoms—such as anxiety, joint pain, and sweating.
In a first, scientists have attempted editing a gene inside the body of a man with Hunter syndrome—a rare and currently incurable disease—in the hopes of changing his DNA and eliminating the disease.
CMS in its proposed rule for Medicare Advantage and Part D plans sought public comment on how to apply at the pharmacy counter certain rebates and discounts that are typically negotiated behind the scenes, among other requests for comment.
Medscape's Malpractice Report 2017 shows more than half of provider respondents have been sued for malpractice—but the likelihood of facing a legal challenge varies significantly by specialty.
As health care consumers increasingly post doctor ratings online, hospitals and physicians have adopted a wide variety of strategies to address negative reviews, ranging from suing commentators for defamation to soliciting additional feedback, Casey Ross writes for STAT News.
